Arax Advisory Partners’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7K Sell
111
-28
-20% -$4.3K ﹤0.01% 2160
2025
Q4
$19.1K Sell
139
-1,131
-89% -$146K ﹤0.01% 2141
2025
Q3
$154K Buy
1,270
+1,261
+14,011% +$136K ﹤0.01% 1361
2025
Q2
$964 Buy
+9
New +$899 ﹤0.01% 2792
2025
Q1
Sell
-111
Closed -$11.9K 2917
2024
Q4
$11.9K Hold
111
﹤0.01% 1427
2024
Q3
$14K Hold
111
﹤0.01% 1249
2024
Q2
$12K Buy
+111
New +$10.8K ﹤0.01% 1179

Other funds holding NHC

Arax Advisory Partners's NHC Position: Q1 2026 in Review

Arax Advisory Partners reduced its National Healthcare (NHC) stake by 20% in Q1 2026, selling an estimated $4.3K and leaving 111 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

Arax Advisory Partners first reported a position in NHC in Q2 2024 and has held it in 7 quarters since. The position peaked at $154K in Q3 2025. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Arax Advisory Partners held 111 shares of National Healthcare worth $17.7K as of Q1 2026.
  • Arax Advisory Partners sold 28 National Healthcare shares in Q1 2026, an estimated $4.3K.
  • National Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2160 holding.
  • Arax Advisory Partners first reported a position in National Healthcare in Q2 2024 and has held it in 7 quarters since.
  • Arax Advisory Partners's National Healthcare position peaked at $154K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.